Long term population impact of seven-valent pneumococcal conjugate vaccine with a “3+0″ schedule—How do “2+1″ and “3+1″ schedules compare?
Abstract
No abstract availableKeywords
Funding Information
- National Centre for Immunisation Research and Surveillance, Australia
- NSW Ministry of Health and the Australian Government Department of Health
- National Health and Medical Research Council of the Australian Government Department of Health
This publication has 20 references indexed in Scilit:
- Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance SitesPLOS Medicine, 2013
- Optimizing the Use of Pneumococcal Conjugate Vaccine Globally2013
- Effect of vaccines on bacterial meningitis worldwideThe Lancet, 2012
- The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: A randomized controlled trialVaccine, 2012
- Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: Systematic review and meta-analysisVaccine, 2011
- Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort studyThe Lancet Infectious Diseases, 2011
- Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate VaccineThe Journal of Infectious Diseases, 2010
- Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years oldThe Lancet Infectious Diseases, 2006
- OCCULT BACTEREMIA IN YOUNG FEBRILE CHILDRENPediatric Clinics of North America, 1999
- Evaluation of a protocol for selective empiric treatment of fever without localising signsArchives of Disease in Childhood, 1997